Press Releases

Poxel Announces Participation at ODDO BHF Forum

Dec 19, 2019

Poxel Announces Positive Results for PXL065 Phase 1b Trial and Provides Program Update

Dec 18, 2019

Poxel Announces Updates to its Management Team

Nov 29, 2019

Poxel Announces Positive Topline Results for Imeglimin Phase 3 Trial (TIMES 3 36-week) for the Treatment of Type 2 Diabetes in Japan

Nov 26, 2019

Poxel Announces Presentation of PXL065 Phase 1a Results at the Liver Meeting® 2019

Nov 12, 2019

Poxel Announces Positive Update Following FDA Meeting for PXL065 for Treatment of NASH

Nov 8, 2019

Poxel to Present Results From Phase 1a Study of PXL065 at the Liver Meeting® 2019

Nov 7, 2019

Poxel to Present at Upcoming Investor Conferences

Nov 7, 2019

Poxel Obtains Additional Funding to Advance Pipeline Programs

Nov 5, 2019

Poxel Announces Participation at the H.C. Wainwright 3rd Annual NASH Investor Conference

Oct 17, 2019